VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer

V-domain Ig suppressor of T-cell activation (VISTA), a newly discovered negative immune checkpoint, is thought to be related to immunotherapy resistance and may become a new immune therapeutic target. Here, we evaluated the expression of VISTA in a cohort containing 254 patients with untreated tripl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xi, Ren, Xinyu, Zhou, Yidong, Mao, Feng, Lin, Yan, Wu, Huanwen, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829913/
https://www.ncbi.nlm.nih.gov/pubmed/33505908
http://dx.doi.org/10.3389/fonc.2020.583966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829913/
https://www.ncbi.nlm.nih.gov/pubmed/33505908
http://dx.doi.org/10.3389/fonc.2020.583966

Ejemplares similares